Globe Life Inc. (NYSE:GL – Get Free Report) EVP Michael Clay Majors sold 34,000 shares of the business’s stock in a transaction on Friday, April 24th. The shares were sold at an average price of $153.81, for a total transaction of $5,229,540.00. Following the completion of the sale, the executive vice president owned 53,518 shares in the company, valued at $8,231,603.58. This represents a 38.85% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.
Michael Clay Majors also recently made the following trade(s):
- On Friday, February 6th, Michael Clay Majors sold 30,000 shares of Globe Life stock. The stock was sold at an average price of $146.89, for a total transaction of $4,406,700.00.
Globe Life Price Performance
NYSE GL traded down $0.39 on Monday, hitting $152.17. 566,629 shares of the company were exchanged, compared to its average volume of 502,808. The firm has a 50 day moving average of $143.66 and a two-hundred day moving average of $139.57. The company has a market cap of $11.94 billion, a P/E ratio of 10.52 and a beta of 0.47. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.39. Globe Life Inc. has a 1-year low of $111.13 and a 1-year high of $155.08.
Globe Life Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, May 1st. Investors of record on Friday, April 3rd will be given a dividend of $0.33 per share. This is a positive change from Globe Life’s previous quarterly dividend of $0.27. The ex-dividend date is Thursday, April 2nd. This represents a $1.32 annualized dividend and a yield of 0.9%. Globe Life’s dividend payout ratio is currently 9.13%.
Analyst Upgrades and Downgrades
GL has been the topic of several research reports. Evercore set a $157.00 price target on shares of Globe Life in a research report on Wednesday, February 18th. Weiss Ratings upgraded shares of Globe Life from a “hold (c+)” rating to a “buy (b)” rating in a research report on Monday, April 13th. Piper Sandler upgraded shares of Globe Life to a “strong-buy” rating in a research report on Thursday, April 2nd. Keefe, Bruyette & Woods reiterated a “moderate buy” rating and set a $168.00 price target on shares of Globe Life in a research report on Thursday, March 26th. Finally, Wells Fargo & Company upped their price target on shares of Globe Life from $171.00 to $172.00 and gave the stock an “overweight” rating in a research report on Friday, April 10th. Two analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, Globe Life presently has an average rating of “Buy” and an average target price of $172.67.
Get Our Latest Stock Analysis on GL
Institutional Inflows and Outflows
Hedge funds have recently modified their holdings of the business. Mather Group LLC. bought a new position in shares of Globe Life in the 3rd quarter valued at about $28,000. Hilton Head Capital Partners LLC bought a new position in shares of Globe Life in the 4th quarter valued at about $30,000. CYBER HORNET ETFs LLC bought a new position in shares of Globe Life in the 2nd quarter valued at about $28,000. MUFG Securities EMEA plc bought a new position in shares of Globe Life in the 2nd quarter valued at about $31,000. Finally, Quent Capital LLC bought a new position in shares of Globe Life in the 3rd quarter valued at about $36,000. Institutional investors own 81.61% of the company’s stock.
About Globe Life
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Recommended Stories
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
